These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 15120609

  • 21. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
    O'Reilly MS.
    EXS; 1997; 79():273-94. PubMed ID: 9002223
    [Abstract] [Full Text] [Related]

  • 22. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, Littlewood-Evans A, Maira SM, Martiny-Baron G, Schnell CR, Sini P, O'Reilly T.
    Clin Cancer Res; 2009 Mar 01; 15(5):1612-22. PubMed ID: 19223496
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of action.
    Ojo-Amaize EA, Nchekwube EJ, Cottam HB, Bai R, Verdier-Pinard P, Kakkanaiah VN, Varner JA, Leoni L, Okogun JI, Adesomoju AA, Oyemade OA, Hamel E.
    Cancer Res; 2002 Jul 15; 62(14):4007-14. PubMed ID: 12124334
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK, Ha JM, O E, Lee BH, Lee SK, Shim BS, Hong YK, Joe YA.
    Cancer Res; 2007 May 15; 67(10):4851-9. PubMed ID: 17510415
    [Abstract] [Full Text] [Related]

  • 32. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin.
    Xiao F, Wei Y, Yang L, Zhao X, Tian L, Ding Z, Yuan S, Lou Y, Liu F, Wen Y, Li J, Deng H, Kang B, Mao Y, Lei S, He Q, Su J, Lu Y, Niu T, Hou J, Huang MJ.
    Gene Ther; 2002 Sep 15; 9(18):1207-13. PubMed ID: 12215887
    [Abstract] [Full Text] [Related]

  • 33. Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells.
    Bandyopadhyay A, Zhu Y, Malik SN, Kreisberg J, Brattain MG, Sprague EA, Luo J, López-Casillas F, Sun LZ.
    Oncogene; 2002 May 16; 21(22):3541-51. PubMed ID: 12032856
    [Abstract] [Full Text] [Related]

  • 34. Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins.
    Magnon C, Galaup A, Mullan B, Rouffiac V, Bouquet C, Bidart JM, Griscelli F, Opolon P, Perricaudet M.
    Cancer Res; 2005 May 15; 65(10):4353-61. PubMed ID: 15899827
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Inhibition of angiogenesis by humulone, a bitter acid from beer hop.
    Shimamura M, Hazato T, Ashino H, Yamamoto Y, Iwasaki E, Tobe H, Yamamoto K, Yamamoto S.
    Biochem Biophys Res Commun; 2001 Nov 23; 289(1):220-4. PubMed ID: 11708802
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth.
    Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R.
    J Biol Chem; 2000 Jan 14; 275(2):1209-15. PubMed ID: 10625665
    [Abstract] [Full Text] [Related]

  • 39. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
    Caunt M, Hu L, Tang T, Brooks PC, Ibrahim S, Karpatkin S.
    Cancer Res; 2006 Apr 15; 66(8):4125-32. PubMed ID: 16618733
    [Abstract] [Full Text] [Related]

  • 40. Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor.
    Ramesh R, Mhashilkar AM, Tanaka F, Saito Y, Branch CD, Sieger K, Mumm JB, Stewart AL, Boquoi A, Dumoutier L, Grimm EA, Renauld JC, Kotenko S, Chada S.
    Cancer Res; 2003 Aug 15; 63(16):5105-13. PubMed ID: 12941841
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.